SG10201709702UA - Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof - Google Patents
Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereofInfo
- Publication number
- SG10201709702UA SG10201709702UA SG10201709702UA SG10201709702UA SG10201709702UA SG 10201709702U A SG10201709702U A SG 10201709702UA SG 10201709702U A SG10201709702U A SG 10201709702UA SG 10201709702U A SG10201709702U A SG 10201709702UA SG 10201709702U A SG10201709702U A SG 10201709702UA
- Authority
- SG
- Singapore
- Prior art keywords
- omega
- alpha
- preparation
- methods
- solid forms
- Prior art date
Links
- -1 di-substituted dihydroxy cyclopentyl compound Chemical class 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915575P | 2013-12-13 | 2013-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201709702UA true SG10201709702UA (en) | 2018-01-30 |
Family
ID=52282957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201709702UA SG10201709702UA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
| SG11201604787SA SG11201604787SA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201604787SA SG11201604787SA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9353079B2 (https=) |
| EP (1) | EP3080096A1 (https=) |
| JP (2) | JP2016539994A (https=) |
| KR (1) | KR20160097310A (https=) |
| CN (1) | CN105814033B (https=) |
| AU (1) | AU2014361794B2 (https=) |
| BR (1) | BR112016013594A8 (https=) |
| CA (1) | CA2933556A1 (https=) |
| CL (2) | CL2016001448A1 (https=) |
| IL (2) | IL245917B (https=) |
| MX (1) | MX2016007717A (https=) |
| RU (1) | RU2730520C2 (https=) |
| SA (1) | SA516371307B1 (https=) |
| SG (2) | SG10201709702UA (https=) |
| UA (1) | UA121108C2 (https=) |
| WO (1) | WO2015089475A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US10765629B2 (en) * | 2017-07-25 | 2020-09-08 | Allergan, Inc. | Solid complex, preparations and uses thereof |
| US20230338194A1 (en) * | 2020-01-29 | 2023-10-26 | Kci Licensing, Inc. | Mutliple fluid pathway connector with foam supports |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES416865A1 (es) * | 1972-07-13 | 1976-03-01 | Pfizer | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. |
| US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| US6602900B2 (en) * | 1992-09-21 | 2003-08-05 | Allergan, Inc. | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US6124344A (en) * | 1993-12-28 | 2000-09-26 | Allergan Sales, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| CA2221110C (en) * | 1995-05-18 | 2009-08-04 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
-
2014
- 2014-12-12 CN CN201480067663.3A patent/CN105814033B/zh not_active Expired - Fee Related
- 2014-12-12 EP EP14824284.5A patent/EP3080096A1/en not_active Withdrawn
- 2014-12-12 AU AU2014361794A patent/AU2014361794B2/en not_active Ceased
- 2014-12-12 UA UAA201606260A patent/UA121108C2/uk unknown
- 2014-12-12 KR KR1020167018489A patent/KR20160097310A/ko not_active Ceased
- 2014-12-12 MX MX2016007717A patent/MX2016007717A/es unknown
- 2014-12-12 WO PCT/US2014/070156 patent/WO2015089475A1/en not_active Ceased
- 2014-12-12 CA CA2933556A patent/CA2933556A1/en not_active Abandoned
- 2014-12-12 US US14/569,210 patent/US9353079B2/en active Active
- 2014-12-12 SG SG10201709702UA patent/SG10201709702UA/en unknown
- 2014-12-12 BR BR112016013594A patent/BR112016013594A8/pt not_active IP Right Cessation
- 2014-12-12 JP JP2016538513A patent/JP2016539994A/ja active Pending
- 2014-12-12 SG SG11201604787SA patent/SG11201604787SA/en unknown
- 2014-12-12 RU RU2016123446A patent/RU2730520C2/ru active
-
2016
- 2016-05-05 US US15/147,700 patent/US20170087163A1/en not_active Abandoned
- 2016-05-30 IL IL245917A patent/IL245917B/en active IP Right Grant
- 2016-06-10 CL CL2016001448A patent/CL2016001448A1/es unknown
- 2016-06-13 SA SA516371307A patent/SA516371307B1/ar unknown
-
2019
- 2019-02-22 CL CL2019000471A patent/CL2019000471A1/es unknown
- 2019-12-23 JP JP2019231685A patent/JP2020073513A/ja active Pending
-
2021
- 2021-06-08 IL IL283810A patent/IL283810A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2933556A1 (en) | 2015-06-18 |
| AU2014361794B2 (en) | 2019-04-04 |
| CN105814033B (zh) | 2019-10-25 |
| CL2016001448A1 (es) | 2017-03-03 |
| IL245917A0 (en) | 2016-08-02 |
| WO2015089475A1 (en) | 2015-06-18 |
| CN105814033A (zh) | 2016-07-27 |
| SG11201604787SA (en) | 2016-07-28 |
| EP3080096A1 (en) | 2016-10-19 |
| JP2020073513A (ja) | 2020-05-14 |
| BR112016013594A2 (https=) | 2017-08-08 |
| US20170087163A1 (en) | 2017-03-30 |
| AU2014361794A1 (en) | 2016-06-16 |
| RU2730520C2 (ru) | 2020-08-24 |
| IL283810A (en) | 2021-07-29 |
| JP2016539994A (ja) | 2016-12-22 |
| CL2019000471A1 (es) | 2019-07-12 |
| US9353079B2 (en) | 2016-05-31 |
| US20150166504A1 (en) | 2015-06-18 |
| MX2016007717A (es) | 2016-09-09 |
| UA121108C2 (uk) | 2020-04-10 |
| KR20160097310A (ko) | 2016-08-17 |
| SA516371307B1 (ar) | 2018-10-04 |
| BR112016013594A8 (pt) | 2020-05-19 |
| IL245917B (en) | 2021-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256625A (en) | Antibodies to cd40 with increased agonistic activity | |
| IL261602A (en) | CD40 antibodies with increased agonistic activity | |
| IL283810A (en) | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use | |
| SG11201703356TA (en) | Management of medication preparation with dynamic processing | |
| GB201302014D0 (en) | Use of an anode catalyst layer | |
| ZA201602970B (en) | Process for the preparation of iopamidol | |
| PT3071247T (pt) | Dispositivo para a construção de pele | |
| IL245474B (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
| PL3030484T3 (pl) | Dynamicznie pozycjonowany statek | |
| IL245476A0 (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
| ZA201603457B (en) | Novel method for the synthesis of agomelatine | |
| EP3065726A4 (en) | Creatine analogs and the use thereof | |
| EP2970319A4 (en) | 6-ACETYLMORPHINE ANALOGUE AND METHOD FOR THE SYNTHESIS AND USE | |
| PL2964607T3 (pl) | Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| ZA201504080B (en) | Combination medicament comprising phenylephrine and paracetamol | |
| GB2510444B (en) | Combination of phenylephrine and paracetamol | |
| ITMI20130605A1 (it) | Procedimento per la preparazione di composti benzoeterodiazolici disostituiti con gruppi benzoditiofenici | |
| TH1401004311B (th) | วิธีการสำหรับการผลิตวัตถุขึ้นรูปด้วยโฟมและวัตถุขึ้นรูปด้วยโฟม | |
| IL246188A0 (en) | A process for the preparation of tiacomycin | |
| CO6990721A2 (es) | Proceso para la preparación de análogos de magnolol | |
| GB201306040D0 (en) | Biocontrol activity surface | |
| TWM475359U (en) | Improved structure of album | |
| ITMI20130889A1 (it) | Procedimento per la preparazione di alcoli alchilici fluorurati | |
| GB201314173D0 (en) | Dynamic positioning vessel |